MCT13 Antibodies

Santa Cruz Biotechnology features a diverse variety of MCT13 monoclonal antibodies for investigating MCT13 protein function and expression patterns. MCT13 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA).MCT13, or Monocarboxylate Transporter 13, facilitates the transport of lactate and other monocarboxylates across cell membranes, playing a crucial role in cellular metabolism and energy production. MCT13 function is particularly important in tissues with high metabolic demands, such as muscle and brain, where it helps maintain pH balance and supports metabolic flexibility. Research focused on MCT13 expression and regulation can provide insights into various physiological and pathological processes, including cancer metabolism and neurodegenerative diseases. MCT13 studies have revealed significant implications for understanding cellular energy dynamics and metabolic adaptations in different tissue types. Investigating MCT13 activity has become increasingly important for developing therapeutic strategies targeting metabolic disorders. Recent findings highlight MCT13's potential involvement in cellular stress responses and adaptation mechanisms. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of MCT13's role in health and disease.